Gut microbiota of preterm infants supplemented with probiotics: sub-study of the ProPrems trial

Gut microbiota of preterm infants supplemented with probiotics: sub-study of the ProPrems trial

Abstract Background The ProPrems trial, a multi-center, double-blind, placebo-controlled randomized trial, previously reported a 54% reduction in necrotizing enterocolitis (NEC) of Bell stage 2 or more from 4.4 to 2.0% in 1099 infants born before 32 completed weeks’ gestation and weighing < 1500 ...

Full description

Bibliographic Details
Main Authors: Erica L. Plummer, Dieter M. Bulach, Gerald L. Murray, Susan E. Jacobs, Sepehr N. Tabrizi, Suzanne M. Garland, for the ProPrems Study Group
Format: Article
Language:English
Published: BMC 2018-11-01
Series:BMC Microbiology
Subjects:
Probiotics
Very preterm infants
Gut microbiota
Necrotizing enterocolitis
Online Access:http://link.springer.com/article/10.1186/s12866-018-1326-1

Internet

http://link.springer.com/article/10.1186/s12866-018-1326-1

Similar Items